Aquilo refers to the Roman god of the northern wind. Located in the northern part of the Netherlands, our aim is to contribute to therapies directed at airflow improvement in lung diseases. We are a spin-off company from the University of Groningen, specialized in asthma, COPD and lung fibrosis pharmacology. We have different well-validated pre-clinical models available to study the effects of your compound, including in vitro, ex vivo and in vivo models. We use several techniques to analyze efficacy of your compound or therapy, including lung function measurements, immunohistochemistry and protein and gene expression analyses. Futhermore, we have experience with functioning as a core lab for multi-center clinical trials. We can support with the evaluation of compounds or interventional therapies in patients.
